Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 745

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 745
---
 month. During the year ended June 30, 2024, the Company recorded a total of $ 14as rent expense (2023 - $ 39).

11. Supplementary statement of cash flows information

|                                                                 |     | Year endedJune 30,2024 |     |     | Year endedJune 30,2023 |     |
| Series C Preferred Stock common stock dividend (note 8)         |     |                        | 173 |     |                        | 362 |
| Series A Preferred Stock cash dividend in accounts payable      |     |                        |   2 |     |                        |   — |
| Non-cashissue costs (note 8)                                    |     |                        |   — |     |                        | 289 |
| Equipment additions reclassified from prepaid expenses          |     |                        |   — |     |                        | 447 |
| Conversion of Series C Preferred Stock to common stock (note 8) |     |                        | 393 |     |                        |   — |
| Income taxes paid                                               |     |                        |   — |     |                        |   — |
| Interest paid                                                   |     |                        |   — |     |                        |   — |

12. Financial risk management Market risk Market risk is the risk that changes in market prices, such as foreign exchange rates, interest rates and equity prices will affect the Company’s income or valuation of its financial instruments. The Company is exposed to financial risk related to fluctuation of foreign exchange rates. Foreign currency risk is limited to the portion of the Company’s business transactions denominated in currencies other than the United Sates dollar, primarily general and administrative expenses incurred in Canadian dollars. The Company believes that the results of operations, financial position and cash flows would be affected by a sudden change in foreign exchange rates but would not impair or enhance its ability to pay its Canadian dollar accounts payable. The Company manages foreign exchange risk by converting its US$ to CA$ as needed. The Company maintains the majority of its cash in US$. As of June 30, 2024, net Canadian dollar denominated accounts payable and accrued liabilities exposure in US$ totaled $ 36. F-27

a) Foreign exchange risk

Foreign exchange risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. If foreign exchange rates were to fluctuate within +/-10%of the closing rate at year-end,the maximum exposure is $ 4.

Balances in foreign currencies at